Business
Press Release Mar 24 2022
Lupin Limited has informed the Exchange about press release dated 24-Mar-2022 titled Lupin Receives Approval from U.S. FDA for Sildenafil for Oral Suspension.
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange about press release dated 24-Mar-2022 titled Lupin Receives Approval from U.S. FDA for Sildenafil for Oral Suspension. View Attachment","length":326,"tagName":"div"}]